Monitored Anesthesia Care Versus General Anesthesia as the Primary Anesthetic for Ankle Amputations.


Journal

Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208

Informations de publication

Date de publication:
11 2021
Historique:
received: 14 10 2020
revised: 27 01 2021
accepted: 29 01 2021
pubmed: 28 2 2021
medline: 26 10 2021
entrez: 27 2 2021
Statut: ppublish

Résumé

The authors hypothesized that monitored anesthesia care (MAC)-either by local sedation or regional anesthesia (RA)-compared with general anesthesia (GA), would be associated with lower odds of significant 30-day postoperative complications and mortality in patients undergoing an ankle amputation. Retrospective cohort study. Inpatient. The authors used data from patients who underwent ankle amputation from the American College of Surgeons National Surgical Quality Improvement Program registry. RA as primary anesthetic. A multivariate logistic regression was used to evaluate the association of primary anesthesia type with the outcomes. The regression analysis included all covariates to test the association of the primary exposure variable (anesthesia type) with each outcome of interest. The odds ratio (OR), with associated 95% confidence interval (CI), was reported for each covariate. There were a total of 3,368 patients undergoing guillotine amputation through the tibia/fibula (n = 2,935) or ankle disarticulation (n = 433). Among these patients, 15.5% (n = 491) received MAC as their primary anesthetic. Among all patients, 11.4% (n = 363) experienced a significant postoperative complication. On multivariate logistic regression, MAC was found to decrease odds of postoperative complications (OR 0.57, 95% CI 0.40-0.82, p = 0.002), but not mortality (OR 1.26, 95% CI 0.87-1.84, p = 0.22). This study showed that MAC was associated with improved outcomes, as opposed to GA, as the primary anesthetic in ankle amputations.

Identifiants

pubmed: 33637421
pii: S1053-0770(21)00094-X
doi: 10.1053/j.jvca.2021.01.057
pii:
doi:

Substances chimiques

Anesthetics 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3283-3287

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Kate H Pool (KH)

Department of Anesthesiology, University of California, San Diego, La Jolla, CA.

Brittany N Burton (BN)

School of Medicine, University of California, San Diego, La Jolla, CA.

Alexander Beletsky (A)

School of Medicine, University of California, San Diego, La Jolla, CA.

John J Finneran (JJ)

Department of Anesthesiology, University of California, San Diego, La Jolla, CA.

Rodney A Gabriel (RA)

Department of Anesthesiology, University of California, San Diego, La Jolla, CA; Division of Biomedical Informatics, University of California, San Diego, La Jolla, CA. Electronic address: ragabriel@health.ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH